| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,833 |
49,428 |
$3.83M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,372 |
7,043 |
$722K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,276 |
6,783 |
$325K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
4,209 |
4,185 |
$316K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,812 |
3,662 |
$279K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,780 |
2,779 |
$243K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,583 |
3,545 |
$212K |
| 87070 |
|
25,845 |
23,253 |
$208K |
| 87184 |
|
25,200 |
22,709 |
$164K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,612 |
4,612 |
$138K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
31,728 |
28,535 |
$125K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,024 |
2,841 |
$121K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,783 |
2,650 |
$118K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,274 |
2,253 |
$107K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,812 |
3,662 |
$93K |
| 99443 |
|
845 |
308 |
$85K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,222 |
1,213 |
$82K |
| 99051 |
|
14,052 |
13,460 |
$75K |
| 69210 |
|
1,709 |
1,659 |
$67K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,536 |
1,531 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
956 |
905 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
592 |
591 |
$41K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
307 |
306 |
$41K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,185 |
2,078 |
$40K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,088 |
4,064 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
737 |
717 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,464 |
1,349 |
$29K |
| 81000 |
|
5,787 |
5,590 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
164 |
164 |
$22K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
299 |
293 |
$13K |
| 90686 |
|
2,196 |
2,188 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
990 |
918 |
$10K |
| 99441 |
|
163 |
144 |
$6K |
| 99201 |
|
175 |
174 |
$6K |
| 99381 |
|
146 |
145 |
$5K |
| 99050 |
|
597 |
579 |
$3K |
| 36406 |
|
247 |
244 |
$2K |
| 87631 |
|
25 |
25 |
$2K |
| 87181 |
|
439 |
434 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
373 |
369 |
$2K |
| 94760 |
|
74,687 |
63,198 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
25 |
$1K |
| 87634 |
|
69 |
69 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
98 |
84 |
$1K |
| 81001 |
|
277 |
277 |
$923.41 |
| 90710 |
|
595 |
594 |
$900.00 |
| 90707 |
|
193 |
192 |
$876.20 |
| 90715 |
|
241 |
241 |
$603.34 |
| 92587 |
|
14 |
14 |
$532.14 |
| 90734 |
|
214 |
214 |
$188.67 |
| 86580 |
|
33 |
33 |
$166.54 |
| 85018 |
|
66 |
66 |
$132.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,228 |
1,219 |
$119.18 |
| 90685 |
|
31 |
31 |
$68.34 |
| 90633 |
|
393 |
393 |
$39.04 |
| 99173 |
|
483 |
482 |
$34.98 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
19 |
19 |
$1.52 |
| 90461 |
|
495 |
493 |
$0.00 |
| 90670 |
|
732 |
731 |
$0.00 |
| 90700 |
|
118 |
118 |
$0.00 |
| 90723 |
|
657 |
656 |
$0.00 |
| 90698 |
|
37 |
35 |
$0.00 |
| 99000 |
|
1,470 |
1,415 |
$0.00 |
| 90647 |
|
305 |
304 |
$0.00 |
| 90696 |
|
163 |
163 |
$0.00 |
| 90697 |
|
110 |
110 |
$0.00 |
| 36416 |
|
56 |
56 |
$0.00 |
| 90744 |
|
33 |
31 |
$0.00 |